RNS Number:6992J
Maelor PLC
07 April 2003


7 April 2003


        MAELOR PLC APPOINTS EXCLUSIVE VOLPLEX DISTRIBUTOR FOR BANGLADESH


Maelor plc, the AIM listed specialist healthcare products company, today
announced the appointment of Sn Medical Care as its exclusive distributor for
its blood volume replacement therapy, Volplex, in Bangladesh.


Dhaka-based Sn Medical Care has specialised in the import and distribution of
life-saving medicines from European and US-based companies since 1997.  Their
product range includes oncology, neurology, pain management, nephrology and
cardiology medicines.


Maelor CEO, Stephen Appelbee, said:


'We are pleased to welcome Sn Medical Care to the growing family of Volplex
distributors.  They already have experience of selling plasma substitute
therapies, and estimate that the Bangladesh market is of a similar size to the
UK, at around #9 million.  We will be making a Product Licence Application
immediately, and would expect to launch late in 2003.'


For further information:

Stephen Appelbee, CEO                        07785 367420

Ann-marie Wilkinson, Beattie Financial:      020 7398 3300


Notes to Editors:

Volplex is a colloid; a large macromolecule of succinylated gelatin capable of
binding water to itself.  It is given as an intravenous infusion to substitute
for blood volume lost by patients suffering from the effects of trauma, surgery
or certain medical conditions that result in hypovolaemia.

                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGRNKOKPFBKKDQK